New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents.
Young-Jung Kim, Shi-Xun Ma, Kwang-Hyun Hur, Youyoung Lee, Yong-Hyun Ko, Bo-Ram Lee, Seon-Kyung Kim, Su-Jeong Sung, Kyeong-Man Kim, Hyoung-Chun Kim, Seok-Yong Lee, Choon-Gon Jang
Archives of Toxicology April 1, 2021 DOI: 10.1007/s00204-021-02980-x (opens in new tab)
The journal has published a correction to this paper. Read the correction (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Mice and rats |
| Interventions | 2C-C 2C-P |
| Keywords | 2c-c 2c-p Neurotoxicity Designer drugs Novel psychoactive substances Nps Synthetic drugs Research chemicals Drug abuse potential Addiction risk Substance abuse Drug seeking behavior Reinforcing properties Brain damage Brain impairment Cognitive impairment Motor skill impairment Memory impairment Dopamine dysregulation Neuroinflammation Neurological effects Brain function impact |
| Citations | 10 |
| Key findings | 2C-C and 2C-P have abuse potential via dopaminergic signaling and induce neurotoxicity through neuroinflammation at high doses. |
Abstract
2C (2C-x) is the general name for the family of phenethylamines containing two methoxy groups at the 2 and 5 positions of the benzene ring. The abuse of 2C family drugs has grown rapidly, although the abuse potential and neurotoxic properties of 2C drugs have not yet been fully investigated. In this study, we investigated the abuse potential and neurotoxicity of 4-chloro-2,5-dimethoxyphenethylamine (2C-C) and 2,5-dimethoxy-4-propylphenethylamine (2C-P). We found that 2C-C and 2C-P produced conditioned place preference in a dose-dependent manner in mice, and increased self-administration in rats, suggesting that 2C-C and 2C-P have abuse potential. To investigate the neurotoxicity of 2C-C and 2C-P, we examined motor performance and memory impairment after high doses of 2C-C and 2C-P. High doses of 2C-C and 2C-P decreased locomotor activity, rota-rod performance, and lower Y-maze test, novel objective recognition test, and passive avoidance test scores. We also observed that 2C-C and 2C-P affected expression levels of the D1 dopamine receptor, D2 dopamine receptor, dopamine transporter, and phospho-dopamine transporter in the nucleus accumbens and the medial prefrontal cortex, and increased c-Fos immuno-positive cells in the nucleus accumbens. Moreover, high doses of 2C-C and 2C-P induced microglial activation, which is involved in the inflammatory reaction in the striatum. These results suggest that 2C-C and 2C-P have abuse potential by affecting dopaminergic signaling and induce neurotoxicity via initiating neuroinflammation at high doses.
Citations in the library
Cited by 7
- Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics Experimental Neurology June 4, 2021
- The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Neurochemical Research April 1, 2023
- Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective. Expert Review of Neurotherapeutics February 1, 2025
- Analytical Challenges and Health Implications of "Tusi" (2C): A Critical Review. Critical Reviews in Analytical Chemistry September 12, 2025
- Toxicodynamic insights of 2C and NBOMe drugs - Is there abuse potential? Toxicology Reports June 1, 2025
and 2 more in the library
Cites 7
- The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European Journal of Pharmacology March 22, 2007
- Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology December 1, 2015
- Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Psychopharmacology March 1, 2014
- Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats. Neuropharmacology November 1, 2018
- Mistaking 2C-P for 2C-B: What a Difference a Letter Makes. Journal of Analytical Toxicology 2017
and 2 more in the library